1. a) Peak forced expiratory volume in 1 s within 3 h post-dosing (peak FEV10–3h) response following once-daily tiotropium Respimat add-on to medium-dose inhaled corticosteroids (ICS) in adults with moderate symptomatic asthma.
a) Peak forced expiratory volume in 1 s within 3 h post-dosing (peak FEV10–3h) response following once-daily tiotropium Respimat add-on to medium-dose inhaled corticosteroids (ICS) in adults with moderate symptomatic asthma. Pooled data (NCT and NCT ); all p< versus placebo. Full analysis set. b) Trough forced expiratory volume in 1 s (FEV1) response following once-daily tiotropium Respimat add-on to medium-dose ICS in adults with moderate symptomatic asthma. Pooled data (NCT and NCT ); all p< versus placebo except salmeterol at week 16 (p=0.0002). Full analysis set. Data are presented as mean±se. c) Seven-question Asthma Control Questionnaire (ACQ-7) responder rate following once-daily tiotropium Respimat add-on to medium-dose ICS in adults with moderate symptomatic asthma. Pooled data (NCT and NCT ). Adjusted mean±sd ACQ-7 score response versus placebo: −0.12±0.04 (p=0.0084) with tiotropium 5 μg; −0.16±0.04 (p=0.0002) with tiotropium 2.5 μg; and −0.20±0.04 (p<0.0001) with salmeterol. Full analysis set. Reproduced and modified from [59] with permission from the publisher.
William W. Busse et al. Eur Respir Rev 2016;25:54-64
©2016 by European Respiratory Society